Russian Federation
Russian Federation
Russian Federation
Abstract. The purpose of the study is to evaluate some aspects of toxicological safety of a specific immunobiostimulant “Transfer factor” in laboratory animal models. Methods. The experiments were performed on mice, rats and guinea pigs. The toxicological safety assessment of the “Transfer factor” preparation included the determination of the following characteristics: chronic toxicity, assessment of specific activity, assessment of embryotoxic and teratogenic properties, assessment of allergenic properties Results. It was established that the introduction of the “Transfer factor” preparation in a chronic toxicological experiment is accompanied by the development of muscle tremor in the rodents’ body, the duration of which depends on the administered dose, route of administration and exposure time, but their body weight increases by 6.29–10.63 %. Autopsy of experimental group animals revealed no visible changes in the arrangement of internal organs and fluid accumulation in the abdominal and pleural cavities, although some pathological changes in color, consistency and size of the lungs, spleen, liver and heart were noted. The mass coefficients of these organs change with an increase in the dose of the administered drug “Transfer factor”, especially with the intraperitoneal route of administration up to 10.39 %. The tested drug in the reaction of lymphocyte blast transformation increases the number of blasts from 0.20 to 1.40 %. The totality of data allows us to state that the drug “Transfer factor” in accordance with GOST 12.1.007-76 belongs to the IV hazard class “low-hazard substances” and it can be recommended for further clinical trials, in which a dosage exceeding 6 ml/kg of live weight will not be used, when administered to laboratory animals, a complex of changes in the internal organs develops. Scientific novelty. The introduction of “Transfer factor” does not affect the condition and functions of the reproductive organs (uterus, ovaries) of pregnant rats, and the drug does not exhibit a negative embryotoxic and teratogenic effect in their body. When studying the allergenic properties of the drug, it was found that it does not cause a general anaphylaxis reaction in the body of guinea pigs, does not irritate the skin in the reaction of immune complexes and the conjunctiva of the eye in the conjunctival test.
transfer factor, acute toxicity, mice, rats, guinea pigs, allergenic properties, leukocyte blast transformation
1. Brai A., Poggialini F., Vagaggini C., Pasqualini C., Simoni S., Francardi V., Dreassi E. Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model. // International Journal of Molecular Sciences. 2023. No. 24 (3). Article number 2296. DOI:https://doi.org/10.3390/ijms24032296. EDN: https://elibrary.ru/QYIMSE
2. Gus'kova T. A. Doklinicheskoe toksikologicheskoe izuchenie lekarstvennyh sredstv kak garantiya bezopasnosti provedeniya ih klinicheskih issledovaniy // Toksikologicheskiy vestnik. 2010. № 5 (104). S. 2–5. EDN: https://elibrary.ru/TQUMYX
3. Martignoni M., Groothuis G. M., de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction // Expert Opinion on Drug Metabolism & Toxicology. 2006. No. 2 (6). Rr. 875–894. DOI:https://doi.org/10.1517/17425255.2.6.875.
4. Federal'nyy zakon RF «Ob obraschenii lekarstvennyh sredstv» № 61 ot 12.04.2010 (red. ot 30.01.2024). Stat'ya 4. Osnovnye ponyatiya, ispol'zuemye v nastoyaschem Federal'nom zakone [Elektronnyy resurs]. URL: https://sudact.ru/law/federalnyi-zakon-ot-12042010-n-61-fz-ob/glava-1/statia-4/ (data obrascheniya: 27.06.2024).
5. Yamagata Y., Yamada H., Horii I. Current status and future perspective of computational toxicology in drug safety assessment under ontological intellection // The Journal of Toxicological Sciences. 2019. No. 44 (11). Rr. 721–735. DOI:https://doi.org/10.2131/jts.44.721.
6. Loiodice S., Nogueira da Costa A., Atienzar F. Current trends in silico, in vitro toxicology, and safety biomarkers in early drug development // Drug and Chemical Toxicology. 2019. No. 42 (2). Rr. 113–121. DOI:https://doi.org/10.1080/01480545.2017.1400044. EDN: https://elibrary.ru/FHJTXP
7. Vasil'ev A. N. Kachestvennye doklinicheskie issledovaniya – neobhodimyy etap razrabotki i vnedreniya v klinicheskuyu praktiku novyh lekarstvennyh preparatov // Antibiotiki i himioterapiya. 2012. № 57 (1-2). S. 41–49. EDN: https://elibrary.ru/QCRZIE
8. Horii I. The principle of safety evaluation in medicinal drug – how can toxicology contribute to drug discovery and development as a multidisciplinary science? // The Journal of Toxicological Sciences. 2016. No. 41 (Special). Rr. SP49–SP67. DOI:https://doi.org/10.2131/jts.41.SP49.
9. Yamagata Y., Yamada H. Ontological approach to the knowledge systematization of a toxic process and toxic course representation framework for early drug risk management. // Scientific Reports. 2020. No. 10 (1). Article number 14581. DOI:https://doi.org/10.1038/s41598-020-71370-7. EDN: https://elibrary.ru/ZTRTSW
10. Ankley G. T., Edwards S. W. The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology // Current Opinion in Toxicology. 2018. No. 9. Rr. 1–7. DOI:https://doi.org/10.1016/j.cotox.2018.03.004.
11. Draskau M. K., Spiller C. M., Boberg J., Bowles J., Svingen T. Developmental biology meets toxicology: contributing reproductive mechanisms to build adverse outcome pathways. // Molecular Human Reproduction. 2020. No. 26 (2). Rr. 111–116. DOI:https://doi.org/10.1093/molehr/gaaa001.
12. Gus'kova T. A. Lekarstvennaya toksikologiya i bezopasnost' lekarstvennyh sredstv // Toksikologicheskiy vestnik. 2014. № 2 (125). S. 2–5. EDN: https://elibrary.ru/ZCORKV
13. Zapadnyuk I. P., Zapadnyuk V. I., Zahariya E. A., Zapadnyuk B. V. Laboratornye zhivotnye. Razvedenie, soderzhanie, ispol'zovanie v eksperimente: uchebnoe posobie / 3-e izd., pererab. i dop. Kiev: Vischa shkola, 1983. 383 s.
14. Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novyh farmakologicheskih veschestv / Pod obschey redakciey chlena-korrespondenta RAMN, professora R. U. Habrieva. 2-izd., pererab. i dop. Moskva: OAO «Izdatel'stvo „Medicina“», 2005. 832 s.
15. Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv / Pod obschey redakciey A. N. Mironova. Ch. 1. Moskva: Grif i K, 2012. 944 s.
16. Burkov P. V., Derho M. A., Rebezov M. B., Scherbakov P. N., Derho A. O., Stepanova K. V. Immunologicheskiy status svinomatok v hode reproduktivnogo cikla i korrekciya ego sostoyaniya biostimulyatorom antigenonapravlennogo deystviya // Agrarnaya nauka. 2023. № 12. S. 58–66. DOI:https://doi.org/10.32634/0869-8155-2023-377-12-58-66. EDN: https://elibrary.ru/NZPYNB
17. Burkov P. V., Shcherbakov P. N., Derkho M. A., Rebezov M. B., Stepanova K. V., Derkho A. O., Ansori A. N. M. Pathological features of the lungs and liver of piglets under conditions of constant vaccination of livestock against circovirus infection // Theory and Practice of Meat Processing. 2023. No. 1. Rr. 4–11. DOI:https://doi.org/10.21323/2414-438X-2023-378-1-4-11. DOI: https://doi.org/10.21323/2414-438X-2023-8-1-4-11; EDN: https://elibrary.ru/PFJLBP
18. Burkov P. V., Derho M. A., Rebezov M. B., Scherbakov P. N. Cirkovirus kak faktor kontroliruyuschiy beremennost' // Agrarnaya nauka. 2023. № 8. S. 27–35. DOI:https://doi.org/10.32634/0869-8155-2023-373-8-27-35. EDN: https://elibrary.ru/JUDEJK
19. Burkov P. V., Rebezov M. B., Derho M. A., Scherbakov P. N., Derho A. O. Immunometabolicheskie osobennosti formirovaniya postvakcinal'nogo immuniteta protiv CVS-2 u svinomatok // Agrarnaya nauka. 2024. № 7. S. 38–48. DOI:https://doi.org/10.32634/0869-8155-2024-384-7-38-48. EDN: https://elibrary.ru/KTMLNO
20. Burkov P. V., Derho M. A., Rebezov M. B., Scherbakov P. N., Derho A. O. Eksperimental'noe issledovanie ostroy toksichnosti vnutrimyshechnoy formy specificheskogo immunobiostimulyatora ‒ transfer-faktora. // Agrarnaya nauka. 2024. № 9. S. 40–47. DOI:https://doi.org/10.32634/0869-8155-2024-386-9-40-47. EDN: https://elibrary.ru/EVTOMP
21. Prikaz Ministerstva zdravoohraneniya Rossiyskoy Federacii ot 01.04.2016 № 199n «Ob utverzhdenii Pravil nadlezhaschey laboratornoy praktiki» [Elektronnyy resurs]. URL: https://normativ.kontur.ru/document?moduleId=1&documentId=278397 (data obrascheniya: 07.06.2024).
22. GOST 33216-2014 Rukovodstvo po soderzhaniyu i uhodu za laboratornymi zhivotnymi. Pravila soderzhaniya i uhoda za laboratornymi gryzunami i krolikami [Elektronnyy resurs]. URL: https://internet-law.ru/gosts/gost/62388 (data obrascheniya: 03.05.2024).
23. GOST 33215-2014 Rukovodstvo po soderzhaniyu i uhodu za laboratornymi zhivotnymi. Pravila oborudovaniya pomescheniy i organizacii procedur [Elektronnyy resurs]. URL: https://internet-law.ru/gosts/gost/61242/ (data obrascheniya: 03.05.2024).
24. GOST 34566-2019 Kombikorma polnoracionnye dlya laboratornyh zhivotnyh. Tehnicheskie usloviya. [Elektronnyy resurs]. URL: https://internet-law.ru/gosts/gost/71578 (data obrascheniya: 03.05.2024).
25. GOST R 51232-98 Voda pit'evaya. Obschie trebovaniya k organizacii i metodam kontrolya kachestva [Elektronnyy resurs]. URL: https://internet-law.ru/gosts/gost/8951 (data obrascheniya: 28.05.2024).
26. Manina I. V., Sergeev V. Yu., Golubcova N. V., Sergeev A. Yu. Modifikaciya reakcii blasttransformacii limfocitov dlya primeneniya v allergologicheskoy praktike // Rossiyskiy bioterapevticheskiy zhurnal. 2018. T. 17, № 2. S. 88–92. DOI:https://doi.org/10.17650/1726-9784-2018-17-2-88-92 EDN: https://elibrary.ru/XPUTXV
27. Andrade E. L., Bento A. F., Cavalli J., Oliveira S. K., Schwanke R. C., Siqueira J. M., Freitas C. S., Marcon R., Calixto J. B. Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies. // Brazilian Journal of Medical and Biological Research. 2016. № 49 (12). Rr. e5646. DOI:https://doi.org/10.1590/1414-431X20165646.
28. Ostroumova T. M., Tolmacheva V. A. Ostroumova O. D. Lekarstvenno-inducirovannyy tremor // Nevrologiya, neyropsihiatriya, psihosomatika. 2022. № 14 (2). S. 4–10. DOI:https://doi.org/10.14412/2074-2711-2022-2-4-10 EDN: https://elibrary.ru/EHNJOA
29. Morgan J. C., Kurek J. A., Davis J. L., Sethi K. D. Insights into Pathophysiology from Medication-induced Tremor // Tremor Other Hyperkinet Mov (N. Y.). 2017. No. 7. Article number 442. DOI:https://doi.org/10.7916/D8FJ2V9Q.
30. Vybornaya K. V., Sokolov A. I., Kobel'kova I. V., Lavrinenko S. V., Klochkova S. V., Nikityuk D. B. Osnovnoy obmen kak integral'nyy kolichestvennyy pokazatel' intensivnosti metabolizma // Voprosy pitaniya. 2017. T. 86. № 5. S. 5–10. DOI:https://doi.org/10.24411/0042-8833-2017-00069. EDN: https://elibrary.ru/ZWAWEV
31. Gifford C. A., Holland B. P., Mills R. L., Maxwell C. L., Farney J. K., Terrill S. J., Step D. L., Richards C. J., Burciaga Robles L. O., Krehbiel C. R. Growth and Development Symposium: Impacts of inflammation on cattle growth and carcass merit. // Journal of Animal Science. 2012. No. 90 (5). Rr. 1438–1451. DOI:https://doi.org/10.2527/jas.2011-4846.
32. Sorokina A. V., Alekseeva S. V., Eremina N. V., Durnev A. D. Opyt provedeniya kliniko-laboratornyh issledovaniy v doklinicheskoy ocenke bezopasnosti lekarstv (chast' 2: biohimicheskie i patomorfologicheskie issledovaniya) // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya. 2019. № 9 (4). S. 272–279. DOI:https://doi.org/10.30895/1991-2919-2019-9-4-272-279. EDN: https://elibrary.ru/CJPNXU
33. Lugovik I. A., Makarova M. N. Toksikologicheskie issledovaniya. Referentnye intervaly massovyh koefficientov vnutrennih organov na vyborke, sostoyaschey iz 1000 autbrednyh krys // Laboratornye zhivotnye dlya nauchnyh issledovaniy. 2021. № 1. DOI:https://doi.org/10.29296/2618723X-2021-01-01. EDN: https://elibrary.ru/WJVBOR
34. Yushkov B. G., Klimin V. G., Severin M. V. Sistema krovi i ekstremal'nye vozdeystviya na organizm / Ekaterinburg: URO RAN, 1999. 199 s. EDN: https://elibrary.ru/SEVLJV
35. Ilina T., Kashpur N., Granica S., Bazylko A., Shinkovenko I., Kovalyova A., Goryacha O., Koshovyi O. Phytochemical Profiles and In Vitro Immunomodulatory Activity of Ethanolic Extracts from Galium aparine L. // Plants (Basel). 2019. № 8 (12). Article number 541. DOI:https://doi.org/10.3390/plants8120541. EDN: https://elibrary.ru/KDHUGB
36. Bulycheva T. I., Deyneko N. L., Grigor'ev A. A. Immunohimicheskaya ocenka stimulyacii limfocitov fitogemaggyutininom reakcii blasttransformacii limfocitov s monoklonal'nymi antitelami KI-67 // Klinicheskaya laboratornaya diagnostika. 2014. № 7. S. 51–54.
37. Pletnev V. V. Study of embryotoxic and teratogenic properties of Medicine No. 60 and evaluation of its effect on the reproductive function of rats. // Journal of Population Therapeutics and Clinical Pharmacology. 2022. No. 29 (1). Rr. e40–e49. DOI:https://doi.org/10.47750/jptcp.2022.885. EDN: https://elibrary.ru/EICLMC
38. Dong Z., Tang S. S., Ma X. L., Tan B., Tang Z. S., Li C. H., Yang Z. H., Zeng J. G. Acute, chronic, and genotoxic studies on the protopine total alkaloids of the Macleaya cordata (willd.) R. Br. in rodents. // Front Pharmacology. 2022. № 13. Rr. 987800. DOI:https://doi.org/10.3389/fphar.2022.987800. EDN: https://elibrary.ru/KODHMR
39. Seegmiller R. E., Cook N., Goodwin K., Leishman T., Graf M. Assessment of Gross Fetal Malformations: The Modernized Wilson Technique and Skeletal Staining. // Methods in Molecular Biology. 2019; № 1965. Rr. 421–434. DOI:https://doi.org/10.1007/978-1-4939-9182-2_27.
40. Borodina A. Yu., Kryshen' K. L., Savchenko A. Yu., Makarova M. N., Makarov V.G. Izuchenie embriotoksicheskogo, fetotoksicheskogo i teratogennogo deystviya novogo protivotuberkuleznogo preparata tiozonid u beremennyh krolikov // Bezopasnost' i risk farmakoterapii. 2023. T. 11, № 2. S. 191–204. DOI:https://doi.org/10.30895/2312-7821-2023-11-2-191-204. EDN: https://elibrary.ru/NUACFD
41. Kryshen' K. L., Katel'nikova A. E., Muzhikyan A. A., Makarova M. N., Makarov V.G. Regulyatornye i metodicheskie aspekty izucheniya allergiziruyuschih svoystv novyh lekarstvennyh sredstv na etape doklinicheskih issledovaniy // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya. 2018. № 8 (1). S. 44–55. DOI:https://doi.org/10.30895/1991-2919-2018-8-1-44-55. EDN: https://elibrary.ru/YTLDTW
42. Ampilogova I. N., Karlina M. V., Makarov V. G., Makarova M. N. Vzaimosvyaz' farmacevticheskoy razrabotki i doklinicheskih issledovaniy (obzor) // Razrabotka i registraciya lekarstvennyh sredstv. 2023. T. 12. № 2. S. 155–163. DOI:https://doi.org/10.33380/2305-2066-2023-12-2-155-163. EDN: https://elibrary.ru/XCAXNC
43. Guschin I. S. Somneniya i nadezhdy v uchenii ob allergii. // Immunologiya. 2023. T. 44, № 4. S. 471–480. DOI:https://doi.org/10.33029/0206-4952-2023-44-4-471-480. EDN: https://elibrary.ru/IDOANJ
